About Gentium Srl (OTCMKTS:GENTY)
Gentium SpA is a biopharmaceutical company focused on the development and manufacture of its product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded deoxyribonucleic acid (DNA) extracted from pig intestines. The Company's development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease ( VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. In February 2014, Jazz Pharmaceuticals PLC acquired the 98% interest in Gentium SpA (Gentium).
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Gentium Srl (OTCMKTS:GENTY) Frequently Asked Questions
What is Gentium Srl's stock symbol?
Gentium Srl trades on the OTCMKTS under the ticker symbol "GENTY."
Who are some of Gentium Srl's key competitors?
Some companies that are related to Gentium Srl include Wetherspoons (JDWPY), Zhejiang Expressway (ZHEXY), Usiminas (USNZY), Jiangsu Expressway (JEXYY), China Coal Energy (CCOZY), Detour Gold (DRGDF), Fenner (FNERF), Boyd Group Income Fund (BFGIF), Boardwalk Real Estate Investment Trust (BOWFF), Dunelm Group (DNLMY), Greencore (GNCGY), Cineplex (CPXGF), Fontera Energy Cor (PEGFF), Fih Mobile (FXCNY), SENIOR (SNIRF), Safestore (SFSHF), Jean Coutu Group (JCOUF) and Drax Group (DRXGY).
Who are Gentium Srl's key executives?
Gentium Srl's management team includes the folowing people:
- Khalid Islam Ph.D., Chairman of the Board, Chief Executive Officer, Interim Scientific Director (Age 61)
- Salvatore Calabrese, Chief Financial Officer, Chief Operating Officer (Age 44)
- Carin Heringa, Senior Vice President, Scientific Director (Age 52)
- Marco Maria Brughera, Director (Age 60)
- Laura Ferro Ph.D., Director (Age 62)
- Gigliola Bertoglio CPA, Independent Director (Age 79)
- Bobby W. Sandage Jr., Ph.D., Independent Director (Age 63)
- Elmar J. Schnee, Independent Director (Age 57)
Has Gentium Srl been receiving favorable news coverage?
Media headlines about GENTY stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Gentium Srl earned a media sentiment score of 0.16 on Accern's scale. They also assigned headlines about the biopharmaceutical company an impact score of 44.73 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Gentium Srl?
Shares of GENTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Gentium Srl's stock price today?
One share of GENTY stock can currently be purchased for approximately $56.10.
How big of a company is Gentium Srl?
Gentium Srl has a market capitalization of $872.64 million.
How can I contact Gentium Srl?
Gentium Srl's mailing address is Piazza XX Settembre, 2, VILLA GUARDIA, 22079, Italy. The biopharmaceutical company can be reached via phone at +39-31-5373200.
MarketBeat Community Rating for Gentium Srl (GENTY)MarketBeat's community ratings are surveys of what our community members think about Gentium Srl and other stocks. Vote "Outperform" if you believe GENTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GENTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Gentium Srl (OTCMKTS:GENTY) Analyst Ratings History
(Data available from 4/23/2016 forward)
Gentium Srl (OTCMKTS:GENTY) Earnings History and Estimates Chart
Gentium Srl (OTCMKTS GENTY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/31/2013||$0.20||$0.22||$15.75 million||$16.19 million||View||Listen|
|8/13/2013||Q2 2013||$0.02||$0.16||$13.49 million||$13.62 million||View||N/A|
|5/14/2013||Q1 2013||($0.08)||$0.06||$8.82 million||$10.51 million||View||N/A|
Gentium Srl (OTCMKTS:GENTY) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Gentium Srl (OTCMKTS GENTY) Insider Trading and Institutional Ownership History
Gentium Srl (OTCMKTS GENTY) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Gentium Srl (OTCMKTS GENTY) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Gentium Srl (OTCMKTS:GENTY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Gentium Srl (OTCMKTS GENTY) Stock Chart for Monday, April, 23, 2018